Candel Therapeutics Inc (CADL)
R&D to Revenue
0.00%
Fiscal year · Period ending:
CADL R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
CADL FY R&D/Revenue (5285.60% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
CADL r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 16,629.6% | |
| 12,142.4% | |
| 7,003.2% | |
| 5,285.6% |